Business Context and Reporting Period
This Form 8-K Current Report was filed by Dakota Gold Corp. on July 24, 2026, with the earliest event reported on that date. The filing addresses significant changes in executive leadership and board composition effective August 18, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Departure of CEO: Dr. Robert Quartermain notified the Board of his retirement as Chief Executive Officer, effective August 18, 2026. He will retain his roles as Director and Board Co-Chair.
- Appointment of CEO: Jack Henris was appointed Chief Executive Officer, effective August 18, 2026. He was also appointed as a Director on the same date.
- Executive Background: Mr. Henris, age 63, has over 35 years of mining experience, including prior roles as President and COO of Dakota Gold (since June 2025), and previous leadership positions at Hycroft Mining, Newmont, Goldcorp, Barrick, and Homestake Mining.
Compensation and Outlook
Mr. Henris's compensation package as CEO includes:
- Base Salary: $360,000 annually, subject to annual evaluation.
- Discretionary Bonus: Up to 75% of base salary contingent on pre-established performance goals.
- Long-Term Incentives: At least $630,000, subject to vesting conditions.
As an employee, Mr. Henris is not an independent director and will not serve on board committees or receive separate director compensation. The filing notes no family relationships with other directors or material interests in transactions requiring disclosure under Item 404(a).
Investor Verification Checklist
- Verify the effective date of the leadership transition (August 18, 2026).
- Review the full press release (Exhibit 99.1) for additional strategic context regarding the transition.
- Confirm the vesting conditions and performance metrics for Mr. Henris's long-term incentive compensation.
- Monitor future filings for the appointment of a new Board Co-Chair to replace Dr. Quartermain's role, if applicable.